Here are five insights:
1. COHERE includes patented porous PEEK Scoria biomaterial technology, which offers an environment for bone tissue ingrowth.
2. Vertera executed an initial soft launch of COHERE in May 2016. Since then, surgeons have implanted more than 400 COHERE devices during anterior cervical fusion surgeries.
3. COHERE represents the first device in clinical use to be made out of PEEK and have porosity.
4. The surgeons who implanted COHERE after the soft launch, are observing patients with early fusion signs with significant body bridging.
5. Vertera will feature the device at the North American Spine Society meeting in Boston from Oct. 25 to Oct. 28.
“Porous PEEK Scoria is a game-changing technology that will make all other PEEK devices obsolete and could lend itself to many future applications,” said Brandon Strenge, MD, of Orthopaedic Institute in Paducah, Ky.
More articles on devices:
Asia-Pacific spine surgery devices market to climb to $3B by 2022: 5 things to know
J&J, Medtronic, St. Jude Medical & more: 17 key notes
A $4B discrepancy: Analysts disagree about how Pfizer’s biosimilar launch will impact Johnson & Johnson’s bottom line
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
